Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Biosimo | 2025 | Grant | $300K | Zürich |
| Hi-D Imaging | 2022 | Grant | $6K | Zürich |
| CREAL | 2025 | Corporate Round | $8.9M | Ecublens |
| Invasight | 2022 | Seed | $4.6M | Zürich |
| Synthara | 2024 | Grant | $5.9M | Zürich |
| b-rayZ | 2025 | Series A | Undisclosed | Zürich |
| Adiposs | 2025 | Series A | $5.0M | Geneva |
| Myriad Optics | 2025 | Pre-Seed | $184K | Zürich |
| Tinamu | 2023 | Seed | $1.2M | Zürich |
| TUUS | 2026 | Debt Financing | $124K | Lausanne |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Biosimo | Grant | $300K | Zürich, Switzerland |
| 52 | Hi-D Imaging | Grant | $6K | Zürich, Switzerland |
| 53 | CREAL | Corporate Round | $8.9M | Ecublens, Switzerland |
| 54 | Invasight | Seed | $4.6M | Zürich, Switzerland |
| 55 | Synthara | Grant | $5.9M | Zürich, Switzerland |
| 56 | b-rayZ | Series A | Undisclosed | Zürich, Switzerland |
| 57 | Adiposs | Series A | $5.0M | Geneva, Switzerland |
| 58 | Myriad Optics | Pre-Seed | $184K | Zürich, Switzerland |
| 59 | Tinamu | Seed | $1.2M | Zürich, Switzerland |
| 60 | TUUS | Debt Financing | $124K | Lausanne, Switzerland |
Biosimo Chemicals produces sustainable chemicals
Hi-D Imaging develops technologies for cardiovascular operations with their fully automated medical image processing software.
CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality.
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
Synthara is an IT consulting firm that offers algorithms, semiconductors, machine learning, IoT, and artificial intelligence services.
b-rayZTM develops artificial intelligence software for quality management and standardization of clinical procedures in radiology.
Adiposs SA is a clinical-stage life science company a first-in-class disruptive imaging product for cancer patients.
Myriad Optics is a new bacterial contamination detection solutions for the food industry.
Tinamu is offering a solution for automated stockpile volume monitoring in warehouses.
Tuus Nutrition is revolutionizing energy gels with revolutionary hydrogel technology.
NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.
Perovskia digitally prints custom solar cells based on patent-protected technology.
Immitra Bio is a pioneer in next-generation gene therapy platforms.
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
SmartHelio is software to prevent downtime in a solar plant
Imverse is a 3D graphics software company that offers real-time simulation and modeling tools for live streaming, gaming, and remote work.
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.
Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment.
Aegis Rider is an augmented reality company that provides spatially anchored information to motorcyclists.
NovoViz develops and manufactures single-photon computational engines for applications at various technological nodes.
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Klepsydra offers software products for high performance data processing and AI at the edge
Aseptuva is an early-stage MedTech startup with the mission to combat Healthcare Associated Infections (HAI).
SmartCardia's patch and cloud SaaS platform is a single solution for complete cardiology practice and remote patient monitoring
Neurosoft Bioelectronics develops minimally invasive brain interfaces to monitor and treat neurological disorders.
Venture Kick has invested in 469 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Venture Kick's top investment sectors include Health Care, Medical, Software, Biotechnology, Medical Device. The firm invests across 46 different industry categories.
Among tracked funding rounds, CREAL received $8.9M in a Corporate Round round. Venture Kick's total known invested capital is $1.7B.
Venture Kick's average investment size is $4.2M across its portfolio of 469 companies.
Recent Venture Kick portfolio additions include Biosimo, Hi-D Imaging, CREAL, Invasight, Synthara. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors